This HTML5 document contains 125 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46937913
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в березні 2006 2006年学术文章 บทความทางวิทยาศาสตร์ სამეცნიერო სტატია scientific article published in March 2006 2006年學術文章 scienca artikolo 2006年學術文章 2006年学术文章 2006年學術文章 мақолаи илмӣ научная статья artículo científico publicado en 2006 artikulong pang-agham מאמר מדעי 2006年学术文章 2006年の論文 artikel ilmiah 2006年學術文章 teaduslik artikkel artigo científico 2006年学术文章 article scientific articolo scientifico naučni članak bài báo khoa học научни чланак article científic vědecký článek 2006年学术文章 مقالة علمية نشرت في مارس 2006 2006年學術文章 vedecký článok научни чланак মার্চ ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия artikull shkencor wetenschappelijk artikel article scientifique bilimsel makale 2006 nî lūn-bûn vitenskapelig artikkel 2006년 논문 artigo científico scientific article published in March 2006 artículu científicu artykuł naukowy videnskabelig artikel articol științific wissenschaftlicher Artikel 2006年学术文章 επιστημονικό άρθρο vetenskaplig artikel scientific article published in March 2006 tieteellinen artikkeli vitskapeleg artikkel artigo científico tudományos cikk
p:P577
wds:Q46937913-561B9AF4-9C47-4F2A-A709-D552E9419636
wdt:P577
2006-03-01T00:00:00Z
p:P407
wds:Q46937913-9C239789-68FF-4D5A-842E-2FB6BB5150EF
wdt:P407
wd:Q1860
p:P2860
wds:Q46937913-18538E7C-89F5-443E-9EAC-9D2B1BB4BAA5 wds:Q46937913-1CC4E9E2-524D-487B-903D-ACA7A2CD56C4 wds:Q46937913-F79DA503-0DDA-4067-8602-04CF4130F6AC wds:Q46937913-A58DE929-8BF1-475F-83B1-4FB5C0C8AB45 wds:Q46937913-9641FF84-5CBC-4C72-8DA2-192863D216D1 wds:Q46937913-67A807D2-9BD6-41B5-8C6D-CDCFF8A41826
wdt:P2860
wd:Q44544763 wd:Q33363081 wd:Q33348702 wd:Q33345317 wd:Q44211035 wd:Q34753416
p:P2093
wds:Q46937913-FFEF55A7-45BA-4A10-8E17-9771F30B9549
wdt:P2093
David H Irwin
rdfs:label
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial. Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
skos:prefLabel
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial. Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
schema:name
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial. Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
p:P50
wds:Q46937913-29230503-A2D7-4FF6-ADFB-FA2D7182B439 wds:Q46937913-29E4A0F2-4008-4EA8-83B0-F576DC3E34F4 wds:Q46937913-3459AD7D-B10D-41AE-845F-645837BCE927 wds:Q46937913-3E033153-82A9-4909-A584-56ED745B7C64 wds:Q46937913-4F0DF18E-E588-498E-B047-72AC5483071E wds:Q46937913-55AA2D4A-6120-4B17-8580-6A546DE8AA13 wds:Q46937913-62866DF3-84B1-4A8B-93A6-C72F345709DF wds:Q46937913-B948F110-8709-4A11-BBF7-D7DFFA74A4BB wds:Q46937913-CF48F136-E975-4500-B456-52C0CBCEA540
wdt:P50
wd:Q87712102 wd:Q88888683 wd:Q87785386 wd:Q88014092 wd:Q117224729 wd:Q108855316 wd:Q66380853 wd:Q61123608 wd:Q28421846
p:P1476
wds:Q46937913-3A050299-98BC-494E-B82F-838BF3185F1A
wdt:P1476
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
p:P304
wds:Q46937913-580A987D-CA2A-47C3-A2E9-A11146732FD9
wdt:P304
1316-1319
p:P31
wds:Q46937913-8B352271-6930-4C24-8353-4F3CED7535D9
wdt:P31
wd:Q13442814
p:P921
wds:Q46937913-2F9FDE1F-FFCE-4359-98B3-5487C4DAAF09 wds:Q46937913-50A9A649-B97F-491E-8BC2-2E7D974CB4A5
wdt:P921
wd:Q467635 wd:Q42824440
p:P698
wds:Q46937913-CCA10FDE-F1C0-4670-BFC8-3E37761334E1
wdtn:P698
n10:16470606
wdt:P698
16470606
p:P1433
wds:Q46937913-1433D5CB-A9AC-49A7-B9E7-236D496CED83
wdt:P1433
wd:Q326041
p:P433
wds:Q46937913-DCD0581A-5069-431C-9DF6-64C51B7C41FB
p:P478
wds:Q46937913-68F92AC0-025D-4EDB-B884-0F2451608DAE
wdt:P433
6
wdt:P478
106
p:P356
wds:Q46937913-BFA0D07B-6A1E-4169-ACD5-297DB051B7BE
wdtn:P356
n11:CNCR.21740
wdt:P356
10.1002/CNCR.21740
p:P5875
wds:Q46937913-1639975E-F72E-4105-BB53-25E6B8E02C87
wdt:P5875
51373380